BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Indirubin

Qingrejiedu [Supplementary Concept] oral liquid with effective components: chlorogenic acid, geniposide, baicalin, forsythin and indirubin Heading Mapped to: Chlorogenic Acid Flavonoids Indoles Bridged Bicyclo Compounds, Heterocyclic Iridoids

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 37.1

Research Domains

Indirubin has been studied across 19 research domains including 🔬 Oncology, 🔬 Inflammation, ✨ Skin & Hair, 🛡️ Immunity, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 39% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Indirubin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

at
13 shared targets
zemirciclib
7 shared targets
rg
13 shared targets
dinaciclib
8 shared targets
fisetin
9 shared targets
alsterpaullone
12 shared targets
azd
7 shared targets
kenpaullone
12 shared targets
bms
13 shared targets
voruciclib
4 shared targets
Loading evidence profile...

This evidence profile for Indirubin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.